Neuroprotectant for Hypertensive Intracerebral Hemorrhage
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 422 participants.
Also called NCT03546283
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 422 participants
- Sponsor
- Rong Hu, MD
- Registry
-
NCT03546283
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03546283. Randomized; quadruple masking; primary purpose treatment. Start 2018-06-15 (anticipated); primary completion 2020-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neuroprotectant for Hypertensive Intracerebral Hemorrhage
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- Placebos
- Intervention (Drug)
- Cattle Encephalon Glycoside and Ignotin
- Lead sponsor
- Rong Hu, MD
Record details
- Record id
cardio:ct-nct03546283- Content hash
763b9da1b7f284a0ffd6a83c62c5020482fd6b6e2b093873a5e5a3249589caef